Skip to main content

Life Sciences is now live. See how →

Patent Examiner Jason E. Flick

Art Unit 3783 · Medical Injectors, Catheters & Infusion Pumps · Tech Center 3700 · 249 applications filed 2021–2026

Average · easier than 62% of examiners● Free examiner data

Jason E. Flick is a USPTO patent examiner in Art Unit 3783 (Medical Injectors, Catheters & Infusion Pumps) with 249 applications from filing years 2021–2026. Examiner Flick's allowance rate is 88.4%, above the 83.3% USPTO average for applications filed in the same years. The examiner ranks easier than 62% of examiners.

Draft a response to Examiner FlickSee the strategy data ↓

Data through October 2026 from USPTO Patent Center (formerly PAIR) · Methodology

Overview

Free
Difficulty · Average
easier than 62% of examiners
Easier37th percentileHarder
Allowance rate vs peers
Examiner Flick88.4%
Art Unit 378379.6%
USPTO average83.3%
Allowance rate
88.4%
▲ USPTO avg 83.3%
Applications
249
filing years 2021–2026
First-action allowance
31.8%
patented with no rejection
Abandoned
8.0%
share of applications
Avg office actions
0.9
USPTO avg 1.3
Days to first OA
834
▲ USPTO 619
RCE rate
16.5%
USPTO 18.9%
Interview rate
6.8%
USPTO 26.8%

Examiner details

  • Art unit3783 · Medical Injectors, Catheters & Infusion Pumps
  • Title / gradePrimary Patent Examiner · GS-14
  • Service18 years
  • Phone(571) 270-7024
  • Email[email protected]
  • LocationAlexandria, VA 22314
  • In USPTO recordsFLICK, JASON E
Full signatory authority

Examiner Flick can allow an application without a supervisory sign-off.

Examines (USPC classes)
604 · Surgery: Instruments & Material Delivery

How to improve your odds with Examiner Flick

  • Plan for the timeline. First office action averages 834 days vs the 619-day USPTO norm.
  • Expect a §112. Definiteness & disclosure is the most-issued rejection (82), and applicants overcame it 80.4% of the time.
  • The data favors an RCE here. Cases with an RCE were allowed more often in all 3 measured years, by 12.5 to 19.0 points.

Historical patterns from this examiner's past cases, shown for general information. This is not legal advice and does not predict the outcome of any specific application. Decisions about interviews, RCEs, and claim strategy should be made with a licensed patent attorney or agent.

Rejection patterns & how they get overcome

Free
§102 Novelty78 issued · 72.5% overcome
§103 Obviousness60 issued · 75.0% overcome
§112 Definiteness & disclosure82 issued · 80.4% overcome
How applicants traverse §112 rejections🔒 Members

Of the 19 winning responses to Examiner Flick's §112 rejections that Boundly has classified, 17 (89%) amended the claims and argued, and 2 amended without arguing. Each winning response, with its arguments and claim amendments, is in the file wrapper.

Read the winning §112 argumentsFull REMARKS, amendments, claim trees & redlines from the file wrappers
Start free

Just got an office action from Examiner Flick?

Draft your response with Examiner Flick's record and Art Unit 3783's history in view, including the rejection patterns and the arguments that have overcome them. See office action responses in AI Studio.

Open AI Studio free →

RCE behavior

Allowance after a Request for Continued Examination versus without one, per year. Use it to judge whether an RCE is worth the cost in front of Examiner Flick.

YearRCE rateAllowance w/ RCEAllowance w/oDelta
202312.0%100.0%84.6%+15.4pp
202225.9%100.0%87.5%+12.5pp
202124.6%100.0%81.0%+19.0pp

Recent outcomes

Free🔒 Case detail for members
App #TitleOutcomeOAsArguments & redline
18/283649Receptacle for Single-Handedly Uncapping, Recapping and Disposing a Syringe's Cap and NeedlePatented1🔒 View
18/238753Infusion Pump Door Seal for Vertical Intravenous TubesPatented1🔒 View
18/212596Systems and Methods for Detecting Disruptions in Fluid Delivery DevicesPatented0🔒 View
18/036682Breast PumpPatented1🔒 View
See all 249 applications with full file-wrapper detailOffice action text, attorney arguments, amendments & claim-by-claim track changes
Start free

Art Unit 3783 technology

Syringes, pens & autoinjectorsCatheters & vascular accessInfusion pumps & insulin deliveryIrrigation & aspirationTop CPC A61M · A61B · G16H
About this examiner. Jason E. Flick examines in Art Unit 3783 (Medical Injectors, Catheters & Infusion Pumps, Tech Center 3700). The art unit's docket includes syringes, pens & autoinjectors, catheters & vascular access, infusion pumps & insulin delivery, and irrigation & aspiration.

Frequently asked questions

What is Examiner Jason E. Flick's allowance rate?
Examiner Flick's allowance rate is 88.4%, compared with 83.3% across the USPTO and 79.6% in Art Unit 3783 for applications filed in the same years. That rate ranks Examiner Flick easier than 62% of examiners.
Is Examiner Flick a hard examiner?
Not especially. Examiner Flick ranks easier than 62% of examiners, in the 37th difficulty percentile (average). Examiner Flick has an 88.4% allowance rate versus 83.3% across the USPTO and 79.6% in Art Unit 3783, 0.9 office actions per application versus 1.3, and an RCE rate of 16.5% versus 18.9% across the USPTO, for applications filed in the same years.
What is Examiner Flick's most common rejection?
§112 definiteness & disclosure, issued 82 times in the data. Applicants overcame it 80.4% of the time. Of the 19 winning responses Boundly has classified, 17 amended the claims and argued.
Is an RCE worth filing with Examiner Flick?
In this examiner's record, yes. Decided applications with an RCE were allowed more often in each of the 3 measured years, by 12.5 to 19.0 percentage points. In 2021, 100.0% of decided applications with an RCE were allowed, versus 81.0% of those without one.
How long until the first office action from Examiner Flick?
About 834 days on average, versus 619 days across the USPTO for applications filed in the same years.
How do I contact Examiner Jason E. Flick?
Examiner Flick can be reached by phone at (571) 270-7024 or by email at [email protected]. The examiner's direct line is also listed at the end of the examiner's office actions.

Put Examiner Flick's data to work on your next response.

Full file-wrapper detail, winning arguments, and AI-assisted drafting in one workspace.

Start free
Statistics are computed by Boundly Prosecution Intel from USPTO Patent Center (formerly PAIR) file wrappers for filing years 2021–2026, refreshed regularly. Allowance rate (sometimes called grant rate) is the share of disposed applications that issued as patents. Office actions here are non-final and final rejections, so restriction requirements and allowances are not counted. USPTO benchmarks are weighted to each examiner's mix of filing years, and art-unit benchmarks to the art units and filing years of the examiner's own applications, so they compare like for like. The difficulty percentile ranks examiners, each counted once, so it can point the other way from the USPTO average, which counts applications. See how each number is computed. The year-by-year interview and RCE tables show up to four recent filing years, leaving out the newest one and any year with fewer than ten applications or five decided applications on either side. Historical data is provided for informational purposes only. Past examiner behavior does not guarantee future outcomes, and nothing here is legal advice or a substitute for advice from a licensed patent attorney or agent. Are you Jason E. Flick, or see an error? Request a correction.